Cunninghamella bertholletiae pneumonia showing a reversed halo sign on chest computed tomography scan following cord blood transplantation

References

• Spellberg B, Walsh TJ, Kontoyiannis DP, Edwards J Jr, Ibrahim AS. Recent advances in the management of mucormycosis: from bench to bedside. Clin Infect Dis 2009; 48: 1743–1751.
   PubMed Web of Science ®Google Scholar
• Wahba H, Truong MT, Lei X, Kontoyiannis DP, Marom EM. Reversed halo sign in invasive pulmonary fungal infections. Clin Infect Dis 2008; 46: 1733–1737.
   PubMed Web of Science ®Google Scholar
• Leaw SN, Chang HC, Sun HF, . Identification of medically important yeast species by sequence analysis of the internal transcribed spacer regions. J Clin Microbiol 2006; 44: 693–699.
   PubMed Web of Science ®Google Scholar
• Kurtzman CP, Robnett CJ. Identification of clinically important Ascomycetous yeasts based on nucleotide divergence in the 5′ end of the large-subunit (26S) ribosomal DNA gene. J Clin Microbiol 1997; 35: 1216–1223.
   PubMed Web of Science ®Google Scholar
• Clinical and Laboratory Standards Institute. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Filamentous Fungi. 2nd ed., approved standard M38-A2. Wayne, PA: Clinical and Laboratory Standards Institute (CLSI); 2008.
   Google Scholar
• Kim SJ, Lee KS, Ryu YH, . Reversed halo sign on high-resolution CT of cryptogenic organizing pneumonia: diagnostic implications. Am J Roentgenol 2003; 180: 1251–1254.
   PubMed Web of Science ®Google Scholar
• Otera H, Tada K, Sakurai T, Hashimoto K, Ikeda A. Reversed halo sign in pneumocystis pneumonia: a case report. BMC Med Imaging 2010; 10: 26.
   Google Scholar
• Marchiori E, Grando RD, Simões Dos Santos CE, . Pulmonary tuberculosis associated with the reversed halo sign on high-resolution CT. Br J Radiol 2010; 83: e58–60.
   Google Scholar
• Tzilas V, Bastas A, Provata A, . The ‘reversed halo’ sign in pneumonococcal pneumonia: a review with a case report. Eur Rev Med Pharmacol Sci 2010; 14: 481–486.
   Google Scholar
• Gasparetto EL, Escuissato DL, Davaus T, . Reversed halo sign in pulmonary paracoccidiomycosis. Am J Roentgenol 2005; 184: 1932–1934.
   PubMed Web of Science ®Google Scholar
• Okubo T, Miyazaki E, Ueo M, . A case of psittacosis with wandering infiltrates developing to acute respiratory distress syndrome. Nihon Kokyuki Gakkai Zasshi 2007; 45: 419–423.
   Google Scholar
• Tokuyasu H, Isowa N, Shimizu E, . Reversed halo sign associated with dermatomyositis. Intern Med 2010; 49: 1677–1678.
   Google Scholar
• Kumazoe H, Matsunaga K, Nagata N, . ‘Reversed halo sign’ of high-resolution computed tomography in pulmonary sarcoidosis. J Thorac Imaging 2009; 24: 66–68.
   Google Scholar
• Benamore RE, Weisbrod GL, Hwang DM, . Reversed halo sign in lymphomatoid granulomatosis. Br J Radiol 2007; 80: e162–166.
   Google Scholar
• Georgiadou SP, Sipsas NV, Marom EM, Kontoyiannis DP. The diagnostic value of halo and reversed halo signs for invasive mold infections in compromised hosts. Clin Infect Dis 2011; 52: 1144–1155.
   PubMed Web of Science ®Google Scholar
• Trifilio S, Singhal S, Williams S, . Breakthrough fungal infections after allogeneic hematopoietic stem cell transplantation in patients on prophylactic voriconazole. Bone Marrow Transplant 2007; 40: 451–456.
   PubMed Web of Science ®Google Scholar
• SM Trifilio, CL Bennett, PR Yarnold, . Breakthrough zygomycosis after voriconazole administration among patients with hematologic malignancies who receive hematopoietic stem-cell transplantation or intensive chemotherapy. Bone Marrow Transplant 2007; 39: 425–429.
   PubMed Web of Science ®Google Scholar
• Rickerts V, Böhme A, Viertel A, . Cluster of pulmonary infections caused by Cunninghamella bertholletiae in immunocompromised patients. Clin Infect Dis 2000; 31: 910–913.
   PubMed Web of Science ®Google Scholar
• Almyroudis NG, Sutton DA, Fothergill AW, Rinaldi MG, Kusne S. In vitro susceptibilities of 217 clinical isolates of zygomycetes to conventional and new antifungal agents. Antimicrob Agents Chemother 2007; 51: 2587–2590.
   PubMed Web of Science ®Google Scholar
• Petrikkos GL. Lipid formulations of amphotericin B as first-line treatment of zygomycosis. Clin Microbiol Infect 2009; 15 (Suppl. 5): 87–92.
   Google Scholar
• Garbino J, Myers C, Ambrosioni J, Gumy-Pause F. Report of a successful treatment of pulmonary Cunninghamella bertholletiae infection with liposomal amphotericin and posaconazole in a child with GvHD and review of the literature. J Pediatr Hematol Oncol 2010; 32: 85–87.
   Google Scholar